ROCKVILLE, Md.--(BUSINESS WIRE)--Feb. 1, 2013--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will
report financial results for the fourth quarter and full year 2012 on
Thursday, March 7, 2013, after market close.
Company management will host a conference call at 5:00 pm Eastern on
March 7, 2013 to discuss the financial results for the fourth quarter
and full twelve months of 2012, recent business developments, revenue
guidance for the first quarter of 2013 and revenue and net income
guidance for full year 2013. The conference call will be accessible by
dialing 888/679-8038 or 617/213-4850 (international) and
providing passcode 76232628. A webcast of the conference call
will be accessible from the company’s website at www.emergentbiosolutions.com,
under “Investors”.
Emergent BioSolutions is offering call participants a pre-registration
option that expedites access to the call and minimizes hold times.
Pre-registrants will be issued a pin number to be used when dialing into
the live call which will provide quick access to the conference call by
bypassing the operator upon connection. Pre-registration, while not
mandatory, can be accessed using the following website: https://www.theconferencingservice.com/prereg/key.process?key=PQUQKA7V3.
A replay of the conference call will be accessible, approximately two
hours following the conclusion of the call, by dialing 888/286-8010 or
617/801-6888 and using the passcode 28122043. The replay will be
available through March 21, 2013. The webcast will be archived on the
company’s website, www.emergentbiosolutions.com,
under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to
protect and enhance life by offering specialized products to healthcare
providers and governments to address medical needs and emerging health
threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Vice President, Corporate
Communications
301-795-1800
SchmittT@ebsi.com
